What is ozempic?

GLP-1 receptor agonist originally for diabetes, widely used off-label for weight loss.

What is ozempic?

GLP-1 receptor agonist originally for diabetes, widely used off-label for weight loss.

Also known as

Quick facts

15–20%
average body weight loss at 12 months on semaglutide
60–70%
of weight regained within 1 year of stopping
$1,000+
monthly retail price without insurance

Common reasons people choose this procedure

Approaches and motivations vary by surgeon and patient anatomy. Compare techniques and real outcomes on the main Ozempic page.

Alternatives

Wegovy

Same molecule as Ozempic, formulated for weight loss specifically. Higher chance of insurance coverage, identical effects.

Mounjaro / Zepbound (tirzepatide)

Newer dual GLP-1/GIP. ~22% body weight loss vs. semaglutide's ~15% in head-to-head trials. Often better tolerated.

Bariatric surgery

Surgical option (gastric sleeve, bypass) with greater long-term efficacy and one-time cost vs. ongoing medication.

More on ozempic

Compare other recovery timeline

Compare other demographic

Compare other ethnicity

Compare other outcome reality

Compare other where it's performed